EA201690135A1 - Трициклические соединения бензоксаборола и их применение - Google Patents
Трициклические соединения бензоксаборола и их применениеInfo
- Publication number
- EA201690135A1 EA201690135A1 EA201690135A EA201690135A EA201690135A1 EA 201690135 A1 EA201690135 A1 EA 201690135A1 EA 201690135 A EA201690135 A EA 201690135A EA 201690135 A EA201690135 A EA 201690135A EA 201690135 A1 EA201690135 A1 EA 201690135A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- benzoxoborol
- application
- tricyclic compounds
- compounds
- mycobacterial
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/69—Boron compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic System
- C07F5/02—Boron compounds
- C07F5/025—Boronic and borinic acid compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic System
- C07F5/02—Boron compounds
- C07F5/04—Esters of boric acids
Abstract
Предложены соединения формулы II, где X выбран из хлора, фтора, брома и йода, каждый из Rи Rнезависимо выбран из Н, -СН, -СНСН, -СНСНСНили -СН(СН); композиции, содержащие их; их применение в терапии, включая их применение в качестве антимикобактериальных агентов, например в лечении микобактериальной инфекции у млекопитающего; и способы получения таких соединений.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361864496P | 2013-08-09 | 2013-08-09 | |
US201361918976P | 2013-12-20 | 2013-12-20 | |
PCT/US2014/050370 WO2015021396A2 (en) | 2013-08-09 | 2014-08-08 | Tricyclic benzoxaborole compounds and uses thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
EA201690135A1 true EA201690135A1 (ru) | 2016-07-29 |
EA032844B1 EA032844B1 (ru) | 2019-07-31 |
Family
ID=52462052
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201690135A EA032844B1 (ru) | 2013-08-09 | 2014-08-08 | Трициклические соединения бензоксаборола и их применение |
Country Status (35)
Country | Link |
---|---|
US (5) | US20160251380A1 (ru) |
EP (2) | EP3030519B1 (ru) |
JP (2) | JP6499175B2 (ru) |
KR (1) | KR102093783B1 (ru) |
CN (2) | CN105492388B (ru) |
AP (1) | AP2016009046A0 (ru) |
AU (2) | AU2014305792C1 (ru) |
BR (1) | BR112016002651B1 (ru) |
CA (1) | CA2919888C (ru) |
CL (1) | CL2016000313A1 (ru) |
CR (1) | CR20160064A (ru) |
CY (1) | CY1125030T1 (ru) |
DK (1) | DK3030519T3 (ru) |
DO (1) | DOP2016000045A (ru) |
EA (1) | EA032844B1 (ru) |
ES (1) | ES2905413T3 (ru) |
HK (1) | HK1219939A1 (ru) |
HR (1) | HRP20220384T1 (ru) |
HU (1) | HUE057365T2 (ru) |
IL (1) | IL243874B (ru) |
LT (1) | LT3030519T (ru) |
MX (1) | MX2016001732A (ru) |
MY (1) | MY175823A (ru) |
NZ (1) | NZ716350A (ru) |
PE (1) | PE20160752A1 (ru) |
PH (1) | PH12016500234A1 (ru) |
PL (1) | PL3030519T3 (ru) |
PT (1) | PT3030519T (ru) |
RS (1) | RS62887B1 (ru) |
SA (1) | SA516370551B1 (ru) |
SG (2) | SG11201600787PA (ru) |
SI (1) | SI3030519T1 (ru) |
UA (1) | UA116908C2 (ru) |
WO (1) | WO2015021396A2 (ru) |
ZA (1) | ZA201600792B (ru) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR094961A1 (es) * | 2013-03-15 | 2015-09-09 | Lilly Co Eli | 1-hidroxi-benzooxaboroles como agentes antiparasitarios |
KR101636431B1 (ko) | 2013-07-30 | 2016-07-05 | 동아에스티 주식회사 | 트리사이클릭 벤즈옥사보롤 화합물, 이의 제조방법 및 용도 |
KR102093783B1 (ko) | 2013-08-09 | 2020-03-26 | 글락소스미스클라인 인털렉츄얼 프로퍼티 (넘버 2) 리미티드 | 트리시클릭 벤족사보롤 화합물 및 이의 용도 |
KR20170024068A (ko) | 2014-07-01 | 2017-03-06 | 다이이찌 산쿄 가부시키가이샤 | 항박테리아제로서의 삼환식 벤즈옥사보롤 |
MA41494B1 (fr) | 2015-02-12 | 2020-10-28 | Glaxosmithkline Ip No 2 Ltd | Composés benzoxaborole substitués en position 4 et utilisations associées |
CN109503637B (zh) | 2016-05-12 | 2021-03-16 | 安纳考尔医药公司 | 用于治疗寄生虫疾病的化合物 |
CN109387594B (zh) * | 2017-08-08 | 2021-01-19 | 武汉武药科技有限公司 | 一种分离和分析贝达喹啉光学异构体的方法 |
JP7296401B2 (ja) * | 2018-01-09 | 2023-06-22 | ハルシオン ラブス プライベート リミテッド | クリサボロールおよびその中間体を調製するためのプロセス |
EP4164645A1 (en) * | 2020-06-15 | 2023-04-19 | The Global Alliance for TB Drug Development, Inc. | Combination antibacterial composition and method for antibacterial therapy |
CN111606850B (zh) * | 2020-07-07 | 2023-07-25 | 安徽贝克生物制药有限公司 | 贝达喹啉及其中间体的制备方法 |
US11793808B2 (en) | 2021-02-22 | 2023-10-24 | Mannkind Corp. | Compositions of clofazimine, combinations comprising them, processes for their preparation, uses and methods comprising them |
WO2023246842A1 (en) * | 2022-06-23 | 2023-12-28 | Shanghai Micurx Pharmaceutical Co., Ltd. | Prodrugs of boron compounds and their use in treating bacterial infections |
WO2023246841A1 (en) * | 2022-06-23 | 2023-12-28 | Shanghai Micurx Pharmaceutical Co., Ltd. | Methods and uses of boron compounds in the treatment of nontuberculous mycobacterium infections and pharmaceutical compositions for treatment of same |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998024753A1 (fr) | 1996-12-02 | 1998-06-11 | Chisso Corporation | Derives de nitro-alcool actifs optiquement, derives d'amino-alcool actifs optiquement et leur procede de preparation |
JP2006508161A (ja) | 2002-12-02 | 2006-03-09 | ソルヴィーアス アクチェンゲゼルシャフト | 炭素−ヘテロ原子二重結合の接触水素化 |
ES2872962T3 (es) * | 2005-02-16 | 2021-11-03 | Anacor Pharmaceuticals Inc | Boronoftalidas para uso terapéutico |
JP5084717B2 (ja) | 2005-03-08 | 2012-11-28 | エージェンシー フォー サイエンス,テクノロジー アンド リサーチ | キラル・ビスオキサゾリン触媒 |
CN101505603A (zh) * | 2005-12-30 | 2009-08-12 | 安纳考尔医药公司 | 含硼的小分子 |
CN106008571A (zh) | 2005-12-30 | 2016-10-12 | 安纳考尔医药公司 | 含硼的小分子 |
KR100848491B1 (ko) | 2007-01-16 | 2008-07-28 | 영진약품공업주식회사 | 베타아미노기를 갖는 2-싸이아졸리딘 유도체, 이의약학적으로 허용 가능한 염 및 이의 제조 방법 |
JO3396B1 (ar) * | 2007-06-20 | 2019-10-20 | Anacor Pharmaceuticals Inc | جزيئات صغيرة تحتوي على البورون |
PE20120052A1 (es) | 2008-12-17 | 2012-02-13 | Anacor Pharmaceuticals Inc | Polimorfos de (s)-3-amino-metil-7-(3-hidroxi-propoxi)-3h-benzo-[c][1,2]-oxaborol-1-ol |
WO2011127143A1 (en) * | 2010-04-07 | 2011-10-13 | Glaxosmithkline Llc | Process for preparing benzoxaboroles |
CN103140228A (zh) * | 2010-09-07 | 2013-06-05 | 阿纳科制药公司 | 苯并氧杂硼杂环戊二烯衍生物用于治疗细菌感染 |
US8530452B2 (en) * | 2011-12-22 | 2013-09-10 | Micurx Pharmaceuticals, Inc. | Tricyclic boron compounds for antimicrobial therapy |
KR101636431B1 (ko) | 2013-07-30 | 2016-07-05 | 동아에스티 주식회사 | 트리사이클릭 벤즈옥사보롤 화합물, 이의 제조방법 및 용도 |
KR102093783B1 (ko) | 2013-08-09 | 2020-03-26 | 글락소스미스클라인 인털렉츄얼 프로퍼티 (넘버 2) 리미티드 | 트리시클릭 벤족사보롤 화합물 및 이의 용도 |
MA41494B1 (fr) * | 2015-02-12 | 2020-10-28 | Glaxosmithkline Ip No 2 Ltd | Composés benzoxaborole substitués en position 4 et utilisations associées |
-
2014
- 2014-08-08 KR KR1020167006314A patent/KR102093783B1/ko active IP Right Grant
- 2014-08-08 MX MX2016001732A patent/MX2016001732A/es active IP Right Grant
- 2014-08-08 RS RS20220108A patent/RS62887B1/sr unknown
- 2014-08-08 DK DK14834292.6T patent/DK3030519T3/da active
- 2014-08-08 PE PE2016000234A patent/PE20160752A1/es unknown
- 2014-08-08 MY MYPI2016700458A patent/MY175823A/en unknown
- 2014-08-08 JP JP2016533471A patent/JP6499175B2/ja active Active
- 2014-08-08 UA UAA201600796A patent/UA116908C2/uk unknown
- 2014-08-08 HU HUE14834292A patent/HUE057365T2/hu unknown
- 2014-08-08 BR BR112016002651-9A patent/BR112016002651B1/pt active IP Right Grant
- 2014-08-08 EA EA201690135A patent/EA032844B1/ru unknown
- 2014-08-08 EP EP14834292.6A patent/EP3030519B1/en active Active
- 2014-08-08 CN CN201480049562.3A patent/CN105492388B/zh active Active
- 2014-08-08 CN CN201811396796.1A patent/CN110003253B/zh active Active
- 2014-08-08 US US14/387,384 patent/US20160251380A1/en not_active Abandoned
- 2014-08-08 WO PCT/US2014/050370 patent/WO2015021396A2/en active Application Filing
- 2014-08-08 AP AP2016009046A patent/AP2016009046A0/en unknown
- 2014-08-08 SG SG11201600787PA patent/SG11201600787PA/en unknown
- 2014-08-08 EP EP21214787.0A patent/EP4029870A1/en not_active Withdrawn
- 2014-08-08 PL PL14834292T patent/PL3030519T3/pl unknown
- 2014-08-08 SG SG10201914073PA patent/SG10201914073PA/en unknown
- 2014-08-08 ES ES14834292T patent/ES2905413T3/es active Active
- 2014-08-08 LT LTEPPCT/US2014/050370T patent/LT3030519T/lt unknown
- 2014-08-08 CA CA2919888A patent/CA2919888C/en active Active
- 2014-08-08 HR HRP20220384TT patent/HRP20220384T1/hr unknown
- 2014-08-08 PT PT148342926T patent/PT3030519T/pt unknown
- 2014-08-08 NZ NZ716350A patent/NZ716350A/en unknown
- 2014-08-08 SI SI201431939T patent/SI3030519T1/sl unknown
- 2014-08-08 AU AU2014305792A patent/AU2014305792C1/en active Active
-
2016
- 2016-01-28 IL IL243874A patent/IL243874B/en active IP Right Grant
- 2016-02-03 PH PH12016500234A patent/PH12016500234A1/en unknown
- 2016-02-04 ZA ZA2016/00792A patent/ZA201600792B/en unknown
- 2016-02-07 SA SA516370551A patent/SA516370551B1/ar unknown
- 2016-02-08 CL CL2016000313A patent/CL2016000313A1/es unknown
- 2016-02-09 DO DO2016000045A patent/DOP2016000045A/es unknown
- 2016-02-09 CR CR20160064A patent/CR20160064A/es unknown
- 2016-07-08 HK HK16107991.6A patent/HK1219939A1/zh unknown
-
2017
- 2017-08-03 AU AU2017210567A patent/AU2017210567B2/en active Active
- 2017-10-24 US US15/792,251 patent/US10308668B2/en active Active
-
2019
- 2019-03-14 JP JP2019046582A patent/JP6764970B2/ja active Active
- 2019-04-16 US US16/385,547 patent/US10526352B2/en active Active
- 2019-11-26 US US16/695,253 patent/US10858376B2/en active Active
-
2020
- 2020-11-04 US US17/089,058 patent/US20210053999A1/en not_active Abandoned
-
2022
- 2022-03-01 CY CY20221100169T patent/CY1125030T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201690135A1 (ru) | Трициклические соединения бензоксаборола и их применение | |
EA201791667A1 (ru) | Соединения бензоксаборола и их применение | |
EA202090255A3 (ru) | 6,7-дигидро-5h-бензо[7]аннуленовые производные в качестве модуляторов эстрогеновых рецепторов | |
EA201891553A1 (ru) | Ингибиторы syk | |
EA201690094A1 (ru) | Ингибиторы syk | |
EA201691085A1 (ru) | Замещенные бензамиды и способы их применения | |
EA201490357A1 (ru) | Индазолы | |
EA201590581A1 (ru) | Соединения бис-(фторалкил)-1,4-бензодиазепинона и их пролекарства | |
EA201990240A1 (ru) | Новые трициклические соединения в качестве противораковых средств | |
EA201390766A1 (ru) | БЕНЗОКСАЗЕПИНЫ КАК ИНГИБИТОРЫ PI3K/mTOR И СПОСОБЫ ИХ ИСПОЛЬЗОВАНИЯ И ПОЛУЧЕНИЯ | |
MY161233A (en) | Bis (fluoroalkyl)-1, 4-benzodiazepinone compounds | |
EA201691044A1 (ru) | Новый октагидро-циклобута[1,2-c;3,4-c']дипиррол-2-ил | |
EA201591296A1 (ru) | Фталазиноны и изохинолиноны в качестве ингибиторов rock | |
EA201592287A1 (ru) | Замещенные тетрагидрокарбазольные и карбазолкарбоксамидные соединения | |
PE20161366A1 (es) | Heterociclil-sulfonas sustituidas con heteroarilo | |
EA201792034A1 (ru) | Замещенные трициклические гетероциклические соединения | |
EA201600434A1 (ru) | Применение производных бензимидазолпролина | |
EA201600636A1 (ru) | 2-амино-6-метил-4,4а,5,6-тетрагидропирано[3,4-d][1,3]тиазин-8а(8н)-ил-1,3-тиазол-4-ил амиды | |
EA202192433A1 (ru) | Соединения, полезные в терапии вич | |
EA201792425A1 (ru) | Трициклические соединения и их применение в качестве ингибиторов фосфодиэстераз | |
EA201700356A1 (ru) | Новые циклопропанбензофуранилпиридопиразиндионы | |
EA201792264A1 (ru) | Способы лечения воспалительных заболеваний | |
EA201690535A1 (ru) | 1,2,4-ТРИАЗОЛО[4,3-a]ПИРИДИНОВЫЕ СОЕДИНЕНИЯ И ИХ ПРИМЕНЕНИЕ В КАЧЕСТВЕ ПОЛОЖИТЕЛЬНЫХ АЛЛОСТЕРИЧЕСКИХ МОДУЛЯТОРОВ РЕЦЕПТОРОВ mGluR2 | |
AR088735A1 (es) | Compuestos de tienopirimidina que son inhibidores de canal de potasio | |
EA201590729A1 (ru) | Производные 3,4-дизамещенного оксазолидинона и их применение в качестве ингибиторов кальцийактивируемых калиевых каналов |